Frank J. Fabio
Director of Finance/CFO at CERES VENTURES, INC.
Frank J. Fabio active positions
Companies | Position | Start | End |
---|---|---|---|
CERES VENTURES, INC. | Director of Finance/CFO | 2013-04-28 | - |
Career history of Frank J. Fabio
Former positions of Frank J. Fabio
Companies | Position | Start | End |
---|---|---|---|
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Director of Finance/CFO | 2008-09-11 | 2009-01-08 |
Corporate Secretary | 2008-09-11 | 2009-01-08 | |
RENOVACARE, INC. | Director of Finance/CFO | 2008-09-11 | 2009-01-08 |
Corporate Secretary | 2008-09-11 | 2009-01-08 | |
SOLARWINDOW TECHNOLOGIES, INC. | Director of Finance/CFO | 2008-09-08 | 2009-01-08 |
Corporate Secretary | 2008-09-08 | 2009-01-08 | |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Director of Finance/CFO | - | 2007-11-13 |
Corporate Secretary | - | 2007-11-13 |
Training of Frank J. Fabio
Pace University | Undergraduate Degree |
Long Island University | Graduate Degree |
Statistics
International
United States | 8 |
Operational
Director of Finance/CFO | 5 |
Corporate Secretary | 4 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
RENOVACARE, INC. | Health Technology |
SOLARWINDOW TECHNOLOGIES, INC. | Producer Manufacturing |
CERES VENTURES, INC. | Health Services |
Private companies | 2 |
---|---|
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Finance |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
- Stock Market
- Insiders
- Frank J. Fabio
- Experience